Taking innovations to industrial scale

Siegfried is a leading contract development and manufacturing organization with a global network of 13 production sites on three continents. With 150 years of pharmaceutical and chemical experience, we are taking your innovations to industrial scale.

Our company

Expect to grow

Visit our careers page

Our offering

As a globally leading contract development and manufacturing organization, we produce pharmaceutical ingredients and finished products as an integrated supplier.

Bringing together our long-standing pharma and chemical heritage

Latest news

Media Release Dec 06, 2024

Changes in Siegfried’s senior management team

Media Release Nov 19, 2024

Siegfried opens new global R&D Center for Drug Substances in Evionnaz

Media Release Nov 12, 2024

DINAMIQS opens new lab in Zurich

Media Release Oct 24, 2024

Strategy EVOLVE+ paves the way for continued profitable growth

Ad hoc

Media Release Sep 04, 2024

EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 7.2% registered shares

Media Release Aug 30, 2024

Siegfried opens new quality control lab in Minden

Ad hoc

Media Release Aug 22, 2024

Siegfried continues to grow and increases profitability

Ad hoc

Media Release Jul 10, 2024

Marcel Imwinkelried appointed as new CEO

Media Release Jul 02, 2024

Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)

Ad hoc

Media Release Jun 14, 2024

EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares

Ad hoc

Media Release Jun 12, 2024

Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering

Media Release Apr 18, 2024

Siegfried increases distribution to the shareholders and all proposals of the Board of Directors are approved